Market Insights
Turner syndrome is a rare disease in which one of the X chromosomes is totally or partially absent. Some of the symptoms of the disease are membranous neck, lymphedema and others. The increasing prevalence of the disease and the increase in the number of women are the main drivers of the market in the evaluation period. In addition, increased FDA approvals and growth in the biotechnology sector, followed by increased awareness of women's health, should stimulate market growth. Most companies investing in R&D to develop a growth hormone that causes fewer side effects and is a long-acting hormone treatment. Technical developments in the field of recombinant human growth hormone should also stimulate the growth of the human growth hormone market during the forecast period.
However, the high annual cost of treatment and associated side effects would hinder market growth over the forecast period. In addition, low per capita health spending in low- and middle-income countries is estimated to dampen market growth.
Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/5160
Market Segmentation
The global market for turner syndrome is segmented based on diagnosis, treatment and end user.
Based on the diagnosis, the market is divided into physical examination, prenatal, karyotyping, and others. The segment of prenatal examinations, by diagnosis, is subdivided into ultrasound, amniocentesis, and chorionic villus sampling.
Based on treatment, the global turner syndrome market is segmented into human growth hormone treatment, estrogen replacement therapy, progesterone replacement therapy, psychological treatment, and others.
For end users, the market is segmented into research organizations, hospitals and clinics, academic institutes, and others.
Get Amazing Discount on Report: https://www.marketresearchfuture.com/check-discount/5160
Market Participants
Medtronic, Pfizer Inc., Cooper Pharma, Rocket Medical plc, Lilly USA, LLC, Genentech, Inc., Novo Nordisk, Smiths Medical, Sanofi, and others are some of the key players in the global turner syndrome market.
No comments:
Post a Comment